Filing Details
- Accession Number:
- 0001104659-20-139741
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-28 16:02:21
- Reporting Period:
- 2020-12-23
- Accepted Time:
- 2020-12-28 16:02:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1805890 | Fusion Pharmaceuticals Inc. | FUSN | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1193586 | Adams Street Partners Llc | 1 N Wacker Dr, Suite 2700 Chicago IL 60606 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-23 | 734 | $12.39 | 562,245 | No | 4 | S | Indirect | See footnotes |
Common Stock | Disposition | 2020-12-23 | 564 | $12.39 | 431,586 | No | 4 | S | Indirect | See footnotes |
Common Stock | Disposition | 2020-12-23 | 547 | $12.39 | 418,645 | No | 4 | S | Indirect | See footnotes |
Common Stock | Disposition | 2020-12-23 | 819 | $12.39 | 626,681 | No | 4 | S | Indirect | See footnotes |
Common Stock | Disposition | 2020-12-23 | 1,905 | $12.39 | 1,458,699 | No | 4 | S | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnotes |
No | 4 | S | Indirect | See footnotes |
No | 4 | S | Indirect | See footnotes |
No | 4 | S | Indirect | See footnotes |
No | 4 | S | Indirect | See footnotes |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.705 to $12.00.
- The shares are held directly by Adams Street 2014 Direct Fund LP ("AS 2014").
- The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015").
- The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016").
- The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017").
- The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI").
- Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.